MedTrace Logo

PMCF Study for Peripheral Arteries Above the Knee (ATK)

NCT05312580 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 387

Last updated 2023-07-27

No results posted yet for this study

Summary

The rationale of this study is to confirm and support the clinical safety and performance of the products in a real-word population of 350 patients who underwent an endovascular intervention within standard-of-care (SOC) of the ilio-femoropopliteal artery, using at least 1 of the products (named above) from Cordis US Corp.

Conditions

  • Peripheral Arterial Disease
  • Femoropopliteal Stenosis
  • Angiopathy, Peripheral

Sponsors & Collaborators

  • FCRE (Foundation for Cardiovascular Research and Education)

    collaborator OTHER

  • Cordis Corporation

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-06-01
Primary Completion
2022-10-07
Completion
2022-11-07

Countries

  • Austria
  • France
  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05312580 on ClinicalTrials.gov